ClinicalTrials.Veeva

Menu

INTER-PATHOLOGIST READER STUDY

O

Orlucent

Status

Invitation-only

Conditions

Nevi, Dysplastic

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This is a post study histology analysis from previously obtained pathology slides.

Full description

This is a post study histology analysis. Pathologists will use digital histology slide scans of suspicious nevus/nevi obtained from previously conducted studies to provide histopathology gradations of histological features as outlined in the Orlucent histology atlas (LBL0713 Histopathology Atlas for Grading of Dysplastic Nevi and DEF0713-1 Histopathology Definitions for LBL0713).

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Histology scans must have been obtained from previous consented subjects that allows post study ad hoc analyses.
  2. Histology scans must be available from the data collected from the Orlucent OMS002, SFI001 or SFI003 Studies and are of good quality.

Exclusion criteria

  • NA

Trial design

500 participants in 1 patient group

suspicious nevus/nevi

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems